RIBASPHERE - 66435-102-16 - (ribavirin)

Alphabetical Index


Drug Information of RIBASPHERE

Product NDC: 66435-102
Proprietary Name: RIBASPHERE
Non Proprietary Name: ribavirin
Active Ingredient(s): 200    mg/1 & nbsp;   ribavirin
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of RIBASPHERE

Product NDC: 66435-102
Labeler Name: Kadmon Pharmaceuticals, LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA077456
Marketing Category: ANDA
Start Marketing Date: 20051205

Package Information of RIBASPHERE

Package NDC: 66435-102-16
Package Description: 168 TABLET, FILM COATED in 1 BOTTLE (66435-102-16)

NDC Information of RIBASPHERE

NDC Code 66435-102-16
Proprietary Name RIBASPHERE
Package Description 168 TABLET, FILM COATED in 1 BOTTLE (66435-102-16)
Product NDC 66435-102
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name ribavirin
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20051205
Marketing Category Name ANDA
Labeler Name Kadmon Pharmaceuticals, LLC
Substance Name RIBAVIRIN
Strength Number 200
Strength Unit mg/1
Pharmaceutical Classes Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC]

Complete Information of RIBASPHERE


General Information